NRXP - NRX Pharmaceuticals, Inc.

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
EPS Growth YoY (%)	—	N/M	-80.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-30.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	-54.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	78.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	53.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-233.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-9.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	23.8% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	97.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	71.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	59.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	74.1% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	15.6% Good ↑ Good Improving Year-over-year change in net income	15.6% Good ↑ Good Improving Year-over-year change in net income	15.6% Good ↑ Good Improving Year-over-year change in net income	-109.6% Weak ↓ Weak Declining Year-over-year change in net income	40.9% Excellent ↓ Excellent Declining Year-over-year change in net income	40.9% Excellent ↑ Excellent Improving Year-over-year change in net income	40.9% Excellent ↑ Excellent Improving Year-over-year change in net income	57.7% Excellent ↑ Excellent Improving Year-over-year change in net income	17.9% Good ↓ Good Declining Year-over-year change in net income	17.9% Good ↓ Good Declining Year-over-year change in net income	17.9% Good ↓ Good Declining Year-over-year change in net income	66.3% Excellent ↑ Excellent Improving Year-over-year change in net income	47.2% Excellent ↑ Excellent Improving Year-over-year change in net income	47.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-1404.7% Weak Weak Year-over-year change in net income	32.6% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	-305766.3% Weak ↓ Weak Declining Year-over-year change in net income	45.4% Excellent → Excellent Stable Year-over-year change in net income	45.4% Excellent ↓ Excellent Declining Year-over-year change in net income	45.4% Excellent Excellent Year-over-year change in net income	N/M	569.3% Excellent Excellent Year-over-year change in net income	N/M	1114.2% Excellent Excellent Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	—	38.1% Excellent Excellent Year-over-year change in free cash flow	7.8% Fair Fair Year-over-year change in free cash flow	—	—	—	—	54.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	44.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	-444.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3060%)	-470.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3236%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	25.3% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.0% Good → Good Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.0% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.0% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.8% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	14.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1219.9% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	55.5% Weak ↓ Weak Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	381.4% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.0% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-133.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1216%)	36.6% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+205%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-402.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-377.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	3.00x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-10.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.20x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	17.76x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	-1.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-2.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-12.78x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	27.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	22.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	12.3% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	8.3% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	—	8.3% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	12.7% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	30.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	31.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	29.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-119.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-201.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-177.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	77.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	81.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	72.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-39.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-77.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-66.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-158.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-60.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-43.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-161.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-92.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1534.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	10.4% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	-2.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	21.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+43%)	15.5% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	21.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+46%)	39.1% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+161%)	34.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+131%)	35.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+137%)	43.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+189%)	36.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+146%)	177.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1084%)	—	—	-138.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1021%)	-80.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-634%)	-53.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-454%)	-42.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-383%)	-146.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1074%)	-284.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1995%)	146.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+874%)	-73.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-588%)	103.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+587%)	8.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-43%)	7.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-50%)	7.2% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-52%)	-0.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-102%)	3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	0.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-96%)	0.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-96%)	-0.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-101%)	0.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-98%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	-1.62x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-370%)	-4.52x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-853%)	-42.92x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-7253%)	1.42x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+137%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	-12.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	-10.76x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	-26.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.44x Weak Weak Operating income divided by interest expense Optimal: > 5x	-145.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	-5235.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-26487.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3744.25x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3351.64x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-9635.41x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-6.71M	$-7.80M	$-7.18M	$-2.91M	$-5.55M	$-1.44M	—	—	$-1.32M	$-4.59M	$1.17M	$-2.28M	$-4.32M	$-9.53M	$-18.25M	$-24.55M	—	$-27.61M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	-1.73x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.55x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.06x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$0.03	—	$0.01	$0.00	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.04	$0.20	$-0.27	$-0.98	—	$-0.77	$-0.15	$-0.75	$-0.74	$-0.50	$-0.70	$-1.20	$-1.60	$-0.15	$-1.40	$-1.10	$-2.10	$-5.30	$-4.00	$-3.80	—	$-13.10	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.13	—	$-0.13	$-0.22	—	—	$-0.21	$-0.24	$-0.41	—	—	—	$-0.90	—	—	—	$-1.63	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.41	$-0.50	$-0.93	$-1.83	$-1.47	$-1.59	$-1.72	$-1.75	$-0.16	$-1.40	$-0.74	$-0.35	$-0.04	$0.11	$2.48	$3.80	$4.76	$3.54	$1.73	$-3.59	$4.54	$-10.19	$11.91	$13.35	$13.90	$17.58	$17.79	$17.85	$17.89	$18.35	$18.95	$19.07	$19.19	$0.00
Tangible Book Value per Share (USD)	$-0.49	$-0.59	$-1.02	$-1.83	$-1.47	$-1.59	$-1.72	$-1.75	$-0.16	$-1.40	$-0.74	$-0.35	$-0.04	$0.11	$2.48	$3.80	$4.76	$3.54	$1.73	$-3.59	$4.54	$-10.19	$11.91	$13.35	$13.90	$17.58	$17.79	$17.85	$17.89	$18.35	$18.95	$19.07	$19.19	$0.00
Basic Weighted Avg Shares (shares)	32.33M	—	22.23M	17.93M	—	—	10.97M	10.52M	8.85M	—	8.19M	7.32M	6.75M	—	6.64M	6.57M	6.37M	—	5.17M	4.17M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$-17.82M	$-19.69M	$-28.65M	$-35.86M	$-25.50M	$-18.56M	—	—	—	$-12.16M	$-6.24M	$-2.83M	$-308.00K	$10.21M	—	—	—	$20.79M	$8.95M	$-16.94M	—	$-43.23M	$-282.09K	$-260.44K	$-235.61K	—	$-433.71K	$-479.87K	$-443.68K	$-537.22K	$-251.76K	$-1.40K	$269.85K	$443.20K
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	$10.07M	$12.69M	$12.19M	$10.53M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-13.82M	$-15.94M	$-25.75M	$-35.62M	$-25.16M	$-23.22M	$-18.82M	$-18.39M	$-15.07M	$-11.73M	$-6.22M	$-2.81M	$-284.00K	$7.41M	$16.78M	$25.35M	$31.69M	$20.81M	$8.97M	$-17.44M	$1.22M	$-43.77M	$3.20M	$3.63M	$3.78M	$5.00M	$5.00M	$5.00M	$5.00M	$5.00M	$5.00M	$5.00M	$5.00M	$0.00

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$1.07M	$983.00K	$242.00K	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$63.00K	$-3.99M	$2.00M	$-20.00K	$0.00	$-990.00K	$0.00	$1.00K	$1.00K	$1.00K	—	—	$1.00K	$1.00K	—	—	$1.00K	$0.00	—	—	—	$890.00	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-1.43M	$360.00K	$-5.51M	$-5.51M	$-5.51M	$-9.08M	$-6.53M	$-6.53M	$-6.53M	$-4.33M	$-11.04M	$-11.04M	$-11.04M	$-10.24M	$-13.45M	$-13.45M	$-13.45M	$-30.41M	$-25.49M	$-25.49M	$-893.72K	$-45.13M	$273.22K	$273.22K	$273.22K	$-14.75K	$187.97K	$187.97K	$187.97K	$29.14K	$28.08K	$-6.60K	$15.48K	—
Operating Cash Flow (USD)	$-4.29M	$-3.71M	$-2.89M	$-4.03M	$-3.48M	$-2.10M	$-2.31M	$-2.56M	$-3.67M	$-3.19M	—	—	$-6.09M	$-8.32M	—	—	$-10.38M	$-11.28M	—	—	$-178.90K	$-406.71K	—	—	$-76.43K	$-262.07K	—	—	$-297.70K	$-70.88K	—	—	$-197.82K	—

NRX Pharmaceuticals, Inc.

Analytical Summary

34-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NRXP with peers